Cohen, Alexa <br/><br/>
Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma.  [electronic resource] 

 -  British journal of haematology  01 2018 
 - 60-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.14992  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Dexamethasone--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Polyethylene Glycols--administration & dosage<br/>Recurrence<br/>Retreatment<br/>Survival Analysis<br/>Thalidomide--administration & dosage<br/>Treatment Outcome